Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWKH
4226
DELISTED
SWK Holdings
SWKH
| $26.6K | ﹤0.01% |
1,975
-1,666
| -46% | -$22.7K |
|
|
DUO
4227
Fangdd Network Group
DUO
$22.1M
| $26.5K | ﹤0.01% |
2,813
| – | – |
|
4228
Mastech Digital
MHH
$93.1M
| $26.3K | ﹤0.01% |
3,502
| – | – |
|
|
KYNB
4229
Kyntra Bio
KYNB
$27.2M
| $26.1K | ﹤0.01% |
1,171
-1,408
| -55% | -$43.5K |
|
|
AILEW
4230
DELISTED
iLearningEngines, Inc. Warrant
AILEW
| $25.8K | ﹤0.01% |
38,200
| – | – |
|
4231
Vor Biopharma
VOR
$1.15B
| $25.8K | ﹤0.01% |
1,288
-636
| -33% | -$20.6K |
|
4232
Verastem
VSTM
$510M
| $25.7K | ﹤0.01% |
8,614
-22,447
| -72% | -$185K |
|
4233
Eve Holding
EVEX
$808M
| $25.6K | ﹤0.01% |
6,329
-17,962
| -74% | -$90.5K |
|
4234
Zura Bio
ZURA
$516M
| $25.6K | ﹤0.01% |
7,304
-5,032
| -41% | -$20.5K |
|
4235
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$429M
| $25.5K | ﹤0.01% |
300
| – | – |
|
4236
Schwab U.S Small- Cap ETF
SCHA
$22.2B
| $25.4K | ﹤0.01% |
1,072
| – | – |
|
4237
Inseego
INSG
$114M
| $25.2K | ﹤0.01% |
2,365
| – | – |
|
4238
Global X Lithium & Battery Tech ETF
LIT
$1.51B
| $25.1K | ﹤0.01% |
648
+425
| +191% | +$18.5K |
|
4239
CVR Partners
UAN
$1.36B
| $25K | ﹤0.01% |
330
-234
| -41% | -$18.6K |
|
4240
Children's Place
PLCE
$54.3M
| $24.9K | ﹤0.01% |
3,065
-5,243
| -63% | -$49.7K |
|
4241
HireQuest
HQI
$180M
| $24.9K | ﹤0.01% |
2,019
-1,841
| -48% | -$23.3K |
|
4242
ProShares Ultra Dow30
DDM
$542M
| $24.9K | ﹤0.01% |
600
-400
| -40% | -$16.5K |
|
|
AE
4243
DELISTED
Adams Resources & Energy Inc
AE
| $24.8K | ﹤0.01% |
885
| – | – |
|
4244
Strawberry Fields REIT
STRW
$191M
| $24.7K | ﹤0.01% |
+2,162
| New | +$21.1K |
|
4245
ClearPoint Neuro
CLPT
$448M
| $24.6K | ﹤0.01% |
4,565
-11,594
| -72% | -$67.1K |
|
4246
Klaviyo
KVYO
$5.34B
| $24.5K | ﹤0.01% |
985
-6,076
| -86% | -$142K |
|
|
GRTS
4247
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $24K | ﹤0.01% |
38,788
-61,529
| -61% | -$52K |
|
|
TECX
4248
Tectonic Therapeutic
TECX
$529M
| $23.7K | ﹤0.01% |
1,441
-1
| -0.1% | -$16 |
|
4249
AirSculpt Technologies
AIRS
$339M
| $23.4K | ﹤0.01% |
5,841
-4,384
| -43% | -$21K |
|
4250
Empire Petroleum
EP
$99.1M
| $23.4K | ﹤0.01% |
4,527
-4,722
| -51% | -$28.4K |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.